WO2014035295A1 - Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни - Google Patents
Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни Download PDFInfo
- Publication number
- WO2014035295A1 WO2014035295A1 PCT/RU2013/000738 RU2013000738W WO2014035295A1 WO 2014035295 A1 WO2014035295 A1 WO 2014035295A1 RU 2013000738 W RU2013000738 W RU 2013000738W WO 2014035295 A1 WO2014035295 A1 WO 2014035295A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prebiotic
- pharmaceutical composition
- pylori
- group
- stomach
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015529748A JP2015526512A (ja) | 2012-08-30 | 2013-08-22 | 胃食道逆流性疾患治療用の医薬組成物 |
US14/422,447 US9713610B2 (en) | 2012-08-30 | 2013-08-22 | Pharmaceutical composition for treating gastro-oesophageal reflux disease |
CN201380042948.7A CN104602671A (zh) | 2012-08-30 | 2013-08-22 | 用于治疗胃食管反流病的药物组合物 |
CA2891457A CA2891457A1 (en) | 2012-08-30 | 2013-08-22 | Pharmaceutical composition for treating gastrooesophageal reflux disease |
EP13832613.7A EP2891483A4 (en) | 2012-08-30 | 2013-08-22 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRO-SOPHAGEAL REFLUX PATHOLOGICAL |
EA201500181A EA201500181A1 (ru) | 2012-08-30 | 2013-08-22 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
IN1160DEN2015 IN2015DN01160A (ru) | 2012-08-30 | 2015-02-12 | |
PH12015500351A PH12015500351A1 (en) | 2012-08-30 | 2015-02-18 | Pharmaceutical composition for treating gastro-oesophageal reflux disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012137067 | 2012-08-30 | ||
RU2012137067/15A RU2501549C1 (ru) | 2012-08-30 | 2012-08-30 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014035295A1 true WO2014035295A1 (ru) | 2014-03-06 |
Family
ID=49785069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2013/000738 WO2014035295A1 (ru) | 2012-08-30 | 2013-08-22 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
Country Status (10)
Country | Link |
---|---|
US (1) | US9713610B2 (ru) |
EP (1) | EP2891483A4 (ru) |
JP (1) | JP2015526512A (ru) |
CN (1) | CN104602671A (ru) |
CA (1) | CA2891457A1 (ru) |
EA (1) | EA201500181A1 (ru) |
IN (1) | IN2015DN01160A (ru) |
PH (1) | PH12015500351A1 (ru) |
RU (1) | RU2501549C1 (ru) |
WO (1) | WO2014035295A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3335716A1 (en) * | 2016-12-15 | 2018-06-20 | Indena S.p.A. | Process for the preparation of powder compositions |
CN108159059A (zh) * | 2017-12-15 | 2018-06-15 | 哈尔滨珍宝制药有限公司 | 一种包含埃索美拉唑钠的药物组合物及其制备方法 |
RU2695067C1 (ru) * | 2019-04-30 | 2019-07-19 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Способ лечения дуоденогастроэзофагеального рефлюкса |
US20220409646A1 (en) * | 2021-06-09 | 2022-12-29 | Isothrive Inc. | Maltosyl-isomalto-oligosaccharides reduce symptoms of gastroesophageal reflux disease |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003184A1 (en) | 1992-07-31 | 1994-02-17 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
WO1999059612A1 (en) | 1998-05-15 | 1999-11-25 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
RU2184734C2 (ru) | 1996-12-20 | 2002-07-10 | Астразенека Аб | S-омепразол в нейтральной форме, способы его получения, фармацевтическая композиция, содержащая s-омепразол в нейтральной форме, и способ лечения связанного с желудочной кислотой состояния |
RU2207339C2 (ru) | 1998-11-10 | 2003-06-27 | Астразенека Аб | Омепразол формы а, способ его получения, фармацевтический препарат на его основе и способ лечения желудочно-кишечных расстройств |
WO2003053221A2 (en) * | 2001-12-19 | 2003-07-03 | Eisai Co. Ltd | Methods using proton pump inhibitors |
US20060165824A1 (en) * | 2005-01-26 | 2006-07-27 | The Procter & Gamble Company | Compositions, kits, and methods for enhancing gastrointestinal health |
RU2361574C2 (ru) | 2003-10-01 | 2009-07-20 | Уайт | Составы пантопразола, состоящие из множества частиц |
EP2201952A1 (en) | 2001-07-09 | 2010-06-30 | Curators Of The University Of Missouri | Omeprazole dosage forms and their use |
EP2208500A1 (en) | 2009-01-16 | 2010-07-21 | Bionap S.r.L. | Compositions for the treatment of gerd (gastroesophageal reflux disease) |
RU2410100C2 (ru) | 2009-03-30 | 2011-01-27 | Александр Владимирович Диковский | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002501897A (ja) * | 1998-01-30 | 2002-01-22 | セプラコール, インク. | R−ランソプラゾール組成物及び方法 |
US7507746B2 (en) * | 2003-02-24 | 2009-03-24 | Mitsubishi Pharma Corporation | Enantiomer of tenatoprazole and the use thereof in therapy |
EP1686976A2 (en) * | 2003-11-05 | 2006-08-09 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
EP1718303A4 (en) * | 2004-02-10 | 2010-09-01 | Santarus Inc | COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG |
EP2012807A4 (en) * | 2006-04-10 | 2009-07-08 | Dikovskiy Aleksander Vladimiro | PHARMACEUTICAL COMPOSITION FROM AN ENTEROSORBEN AND PREBIOTIKA, DOSAGE FORMS AND METHOD FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES |
CN101317604B (zh) * | 2008-07-09 | 2011-07-20 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种添加益生元适合孕妇饮用的液态奶 |
-
2012
- 2012-08-30 RU RU2012137067/15A patent/RU2501549C1/ru active IP Right Revival
-
2013
- 2013-08-22 CA CA2891457A patent/CA2891457A1/en not_active Abandoned
- 2013-08-22 JP JP2015529748A patent/JP2015526512A/ja active Pending
- 2013-08-22 US US14/422,447 patent/US9713610B2/en active Active
- 2013-08-22 WO PCT/RU2013/000738 patent/WO2014035295A1/ru active Application Filing
- 2013-08-22 EA EA201500181A patent/EA201500181A1/ru unknown
- 2013-08-22 EP EP13832613.7A patent/EP2891483A4/en not_active Withdrawn
- 2013-08-22 CN CN201380042948.7A patent/CN104602671A/zh active Pending
-
2015
- 2015-02-12 IN IN1160DEN2015 patent/IN2015DN01160A/en unknown
- 2015-02-18 PH PH12015500351A patent/PH12015500351A1/en unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003184A1 (en) | 1992-07-31 | 1994-02-17 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
RU2184734C2 (ru) | 1996-12-20 | 2002-07-10 | Астразенека Аб | S-омепразол в нейтральной форме, способы его получения, фармацевтическая композиция, содержащая s-омепразол в нейтральной форме, и способ лечения связанного с желудочной кислотой состояния |
WO1999059612A1 (en) | 1998-05-15 | 1999-11-25 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
RU2207339C2 (ru) | 1998-11-10 | 2003-06-27 | Астразенека Аб | Омепразол формы а, способ его получения, фармацевтический препарат на его основе и способ лечения желудочно-кишечных расстройств |
EP2201952A1 (en) | 2001-07-09 | 2010-06-30 | Curators Of The University Of Missouri | Omeprazole dosage forms and their use |
WO2003053221A2 (en) * | 2001-12-19 | 2003-07-03 | Eisai Co. Ltd | Methods using proton pump inhibitors |
RU2361574C2 (ru) | 2003-10-01 | 2009-07-20 | Уайт | Составы пантопразола, состоящие из множества частиц |
US20060165824A1 (en) * | 2005-01-26 | 2006-07-27 | The Procter & Gamble Company | Compositions, kits, and methods for enhancing gastrointestinal health |
EP2208500A1 (en) | 2009-01-16 | 2010-07-21 | Bionap S.r.L. | Compositions for the treatment of gerd (gastroesophageal reflux disease) |
RU2410100C2 (ru) | 2009-03-30 | 2011-01-27 | Александр Владимирович Диковский | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки |
Non-Patent Citations (5)
Title |
---|
EVERHART J.E., II GASTROENTEROL. CLIN. NORTH AMER., vol. 29, 2000, pages 559 - 578 |
EXPERIMENTAL AND CLINICAL GASTROENTEROLOGY, vol. 5, 2010, pages 113 - 118 |
LINEVSKY JU.V. ET AL.: "Sovremennye podkhody k diagnostike i lecheniju gastroezofagealnoi refljuksnoi bolezni.", GAZETA ''NOVOSTI MEDITSINY I FARMATSII'' GASTROENTEROLOGIYA, 2011, pages 390, XP055185415, Retrieved from the Internet <URL:http://www.mif-ua.com/archive/article_print/22631> * |
MALFERTHEINER P.; MEGRAUD F.; O'MORAIN C.A. ET AL.: "Management of Helicobacter pylori infection - the Maastricht IV. / Florence Consensus Report", GUT, vol. 61, 2012, pages 646 - 664 |
See also references of EP2891483A4 |
Also Published As
Publication number | Publication date |
---|---|
JP2015526512A (ja) | 2015-09-10 |
IN2015DN01160A (ru) | 2015-06-26 |
EP2891483A4 (en) | 2016-05-04 |
RU2501549C1 (ru) | 2013-12-20 |
EA201500181A1 (ru) | 2015-05-29 |
CA2891457A1 (en) | 2014-03-06 |
CN104602671A (zh) | 2015-05-06 |
PH12015500351A1 (en) | 2015-04-20 |
US9713610B2 (en) | 2017-07-25 |
EP2891483A1 (en) | 2015-07-08 |
US20150202192A1 (en) | 2015-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6444358B2 (ja) | ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法 | |
KR101228608B1 (ko) | 프로바이오틱 박테리아 기초 조성물 및 호흡기 병리 및/또는 감염의 예방 및/또는 치료 및 장 기능성 개선에 있어서 그들의 용도 | |
EP2712318B1 (en) | Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmalogical treatment of gastric hyperacidity | |
RU2410100C2 (ru) | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки | |
CN108348536B (zh) | 治疗抗生素相关性并发症的合成组合物 | |
RU2501549C1 (ru) | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни | |
Chitapanarux et al. | Effect of Bifidobacterium longum on PPI-based triple therapy for eradication of Helicobacter pylori: A randomized, double-blind placebo-controlled study | |
WO2021097288A1 (en) | Compositions and methods for treating neurodegenerative diseases | |
RU2737891C2 (ru) | Применение антибиотиков со специфичными терапевтическими активностями в комбинации с одновременным применением лактобацилл и/или бифидобактерий с непередающейся устойчивостью к антибиотикам, имеющих такое же терапевтическое показание | |
Wang et al. | Polypharmacology in clinical applications: gastrointestinal polypharmacology | |
CN110448569B (zh) | 一种具有止泻功效的组合物及其制备方法和其应用 | |
WO2021142353A1 (en) | Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv) | |
Daley | The gastrointestinal system | |
Namiot et al. | Vitamin C does not improve the efficacy of Helicobacter pylori eradication in smokers | |
Ameen et al. | The Effect of Probiotic Supplement as Adjuvant Therapy on Dyspeptic Symptoms and Quality of Life during Helicobacter pylori Eradication Therapy in a Sample of Iraqi Patients with Peptic Ulcer Disease | |
Morozov | Helicobacter Pylori Eradication-A New Look at Old Problems | |
Taheri et al. | Therapeutic effects of probiotics and herbal medications on oxalate nephrolithiasis: a mini systematic review | |
US20220054538A1 (en) | Anti-helicobacter agent and method for the use thereof | |
Fedorowicz et al. | Helicobacter pylori: Historical therapy and current treatment Helicobacter pylori–dotychczasowa terapia i leczenie współczesne | |
Rustamov et al. | Probiotics as an anti-helicobacter remedy in the treatment of patients with duodenal ulcer | |
WO2021142347A1 (en) | Compositions and methods for non-alcoholic steatohepatitis (nash) | |
Osborne | Infection With Helicobacter pylori: Pathogenesis, Diagnosis, and Management | |
MALDONADO | Zinc-Carnosine: An Exciting Approach to Gastric Mucosal Health and Dyspeptic Symptom Relief | |
Uspensky et al. | The scheme of treatment of erosive reflux esophagitis. Gaviscon or Phosphalugel: which is better in the treatment of gastrointestinal disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13832613 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201500982 Country of ref document: UA |
|
ENP | Entry into the national phase |
Ref document number: 2015529748 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12015500351 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14422447 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201500181 Country of ref document: EA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2891457 Country of ref document: CA |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015003840 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112015003840 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150223 |